References
- Sareen S, Mathew G, Joseph L. Improvement in solubility of poor water-soluble drugs by solid dispersion. Int J Pharm Investig 2012;2:12–17
- Gomez-Orellana I. Strategies to improve oral drug bioavailability. Expert Opin Drug Deliv 2005;2:419–433
- Fasinu P, Pillay V, Ndesendo VM, et al. Diverse approaches for the enhancement of oral drug bioavailability. Biopharm Drug Dispos 2011;32:189–205
- Balakrishnan P, Lee BJ, Oh DH, et al. Enhanced oral bioavailability of dexibuprofen by a novel solid self-emulsifying drug delivery system. Eur J Pharm Biopharm 2009;72:539–545
- Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47–60
- Miller DA, McCorville JT, Yang W, et al. Hot-melt extrusion for enhanced delivery of drug particles. J Pharm Sci 2007;96:361–376
- Konno H, Handa T, Alonzo DE, Taylor LS. Effect of polymer type on dissolution profile of amorphous solid dispersion containing felodipine. Eur J Pharm Biopharm 2008;70:493–499
- Tiwari R, Tiwari G, Srivastava B, Rai AK. Solid dispersions: an overview to modify bioavailability of poorly water soluble drugs. Int J Pharm Tech Res 2009;1:1338–1349
- Goldberg AH, Gibaldi M, Kanig JL. Increasing dissolution rates and gastrointestinal absorption of drugs via solid solutions and eutectic mixtures. Theoretical considerations and discussion of the literature. J Pharm Sci 1965;54:1145–1148
- Chiou WL, Riegelman S. Pharmaceutical applications of solid dispersion systems. J Pharm Sci 1971;60:1281–1302
- Chokshi RJ, Zia H, Sandhu HK, et al. Improving the dissolution rate of a poorly water soluble drug by solid dispersion and solid solution – pros and cons. Drug Deliv 2007;14:33–45
- Tran TH, Poudel BK, Marasini N, et al. Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique. Arch Pharm Res 2013;36:86–93
- De Beule K, Van Gestel J. Pharmacology of itraconazole. Drugs 2001;61:27–37
- Amidon GL, Lennernäs H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutics drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413–420
- Peeters J, Neeskens P, Tollenaere JP, et al. Characterization of the interaction of 2-hydroxypropyl-beta-cyclodextrin with itraconazole at pH 2, 4, and 7. J Pharm Sci 2002;91:1414–1422
- The Internet Drug Index (www.rxlist.com/sporanox-oral-solution-drug.htm). Last reviewed on RxList 12 Apr 2012
- The Internet Drug Index (www.rxlist.com/sporanox-drug.htm). Last reviewed on RxList 23 Aug 2010
- Dries MKJ, Willy MAC. Oral formulations on an antifungal. US Patent 5707975, 1998
- Gilis PMV, De Condé VFV, Vandecruys RPG. Beads having a core coated with an antifungal and a polymer. US Patent 5,633,015, 1997
- European Pharmacopoeia. 7th ed. Powder flow; 2.9.36. 2011:320–323
- Food & Drug Administration. Guidelines for industry – dissolution testing of immediate release solid oral dosage forms, 1997
- Gramaglia D, Conway BR, Kett VL, et al. High speed DSC (hyperDSC) as a tool to measure the solubility of a drug within a solid or semi-solid matrix. Int J Pharm 2005;301:1–5
- Saunders M, Podluii K, Shergill S, et al. The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples. Int J Pharm 2004;274:35–40